Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004351
Filing Date
2018-05-08
Accepted
2018-05-08 17:19:45
Documents
86
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20180331x10q.htm 10-Q 1658044
2 EX-10.1 arlz-20180331ex101513781.htm EX-10.1 164132
3 EX-31.1 arlz-20180331ex3114f052f.htm EX-31.1 15563
4 EX-31.2 arlz-20180331ex312a6fc93.htm EX-31.2 19156
5 EX-32.1 arlz-20180331ex3215274fe.htm EX-32.1 10990
6 EX-32.2 arlz-20180331ex32237dc5a.htm EX-32.2 11056
  Complete submission text file 0001558370-18-004351.txt   7474235

Data Files

Seq Description Document Type Size
7 EX-101.INS arlz-20180331.xml EX-101.INS 1648708
8 EX-101.SCH arlz-20180331.xsd EX-101.SCH 58427
9 EX-101.CAL arlz-20180331_cal.xml EX-101.CAL 52307
10 EX-101.DEF arlz-20180331_def.xml EX-101.DEF 201785
11 EX-101.LAB arlz-20180331_lab.xml EX-101.LAB 490943
12 EX-101.PRE arlz-20180331_pre.xml EX-101.PRE 385217
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 18815823
SIC: 2834 Pharmaceutical Preparations